Acquisition Announced Sponsor exit

Novanta acquisition of Riverpoint Medical

US$1.2bn consideration

Announced 11 Jun 2026

Advisers

Riverpoint Medical

Target

Novanta

Acquirer

Financial adviser
Target
Riverpoint Medical
Acquirer
Novanta
Seller
Arlington Capital Partners
Target based in
United States (unverified)
Buyer based in
United States
Seller based in
United States
Sector
Medtech

In the league tables

Similar deals

All medtech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.